scholarly article | Q13442814 |
P356 | DOI | 10.1152/AJPCELL.1996.270.6.C1695 |
P698 | PubMed publication ID | 8764152 |
P2093 | author name string | Ausiello DA | |
Holtzman EJ | |||
Hozawa S | |||
P2860 | cites work | Membrane localization of the pertussis toxin-sensitive G-protein subunits alpha i-2 and alpha i-3 and expression of a metallothionein-alpha i-2 fusion gene in LLC-PK1 cells | Q24557949 |
Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine | Q28118727 | ||
Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus | Q28280046 | ||
Expression of a human placental alkaline phosphatase gene in transfected cells: use as a reporter for studies of gene expression | Q33643601 | ||
Characterization of the human tryptophan hydroxylase gene promoter. Transcriptional regulation by cAMP requires a new motif distinct from the cAMP-responsive element. | Q38298561 | ||
Regulation of human calcitonin gene transcription by cyclic AMP | Q38323644 | ||
Expression and distribution of aquaporin of collecting duct are regulated by vasopressin V2 receptor in rat kidney | Q40337519 | ||
Amplification of the transcriptional signal mediated by the tandem cAMP response elements of the glycoprotein hormone alpha-subunit gene occurs through several distinct mechanisms | Q41138275 | ||
Cloning and expression of apical membrane water channel of rat kidney collecting tubule | Q48133572 | ||
A cyclic AMP- and phorbol ester-inducible DNA element | Q59069805 | ||
P433 | issue | 6 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | C1695-702 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | American Journal of Physiology | Q2160146 |
P1476 | title | cAMP motifs regulating transcription in the aquaporin 2 gene | |
P478 | volume | 270 |
Q42149750 | AQP2 is necessary for vasopressin- and forskolin-mediated filamentous actin depolymerization in renal epithelial cells |
Q45178527 | Angiotensin II AT1 receptor blockade decreases vasopressin-induced water reabsorption and AQP2 levels in NaCl-restricted rats |
Q28581163 | Angiotensin II and hypertonicity modulate proximal tubular aquaporin 1 expression |
Q35689507 | Anthrax edema toxin impairs clearance in mice |
Q34310224 | Aquaporin-2 regulation in health and disease. |
Q48300105 | Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries |
Q34107691 | Aquaporins in the kidney: from molecules to medicine |
Q24650150 | Bypassing vasopressin receptor signaling pathways in nephrogenic diabetes insipidus |
Q34457240 | Calcitonin has a vasopressin-like effect on aquaporin-2 trafficking and urinary concentration |
Q38022489 | Cell biology of vasopressin-regulated aquaporin-2 trafficking. |
Q36309457 | Chronic use of chloroquine disrupts the urine concentration mechanism by lowering cAMP levels in the inner medulla |
Q34446433 | Combined proteomics and pathways analysis of collecting duct reveals a protein regulatory network activated in vasopressin escape |
Q52536017 | Decreased renal Na-K-2Cl cotransporter abundance in mice with heterozygous disruption of the G(s)alpha gene. |
Q43954625 | Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla. |
Q40184928 | Downregulation of vasopressin V2 receptor promoter activity via V1a receptor pathway |
Q36467442 | Effect of Atractylodes macrocephala on Hypertonic Stress-Induced Water Channel Protein Expression in Renal Collecting Duct Cells |
Q43568357 | Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. |
Q35178630 | Expression of a dominant negative PKA mutation in the kidney elicits a diabetes insipidus phenotype |
Q33702416 | GSK3beta mediates renal response to vasopressin by modulating adenylate cyclase activity |
Q51416200 | Genome-Wide Mapping of DNA Accessibility and Binding Sites for CREB and C/EBPβ in Vasopressin-Sensitive Collecting Duct Cells. |
Q35178606 | Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice |
Q37139392 | Glycogen synthase kinase-3 regulation of urinary concentrating ability |
Q77220734 | Hyponatremia in cirrhosis: from pathogenesis to treatment |
Q39591507 | Hypotonicity-induced reduction of aquaporin-2 transcription in mpkCCD cells is independent of the tonicity responsive element, vasopressin, and cAMP |
Q28589823 | Impaired solute accumulation in inner medulla of Clcnk1-/- mice kidney |
Q51149601 | Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. |
Q52656382 | Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development. |
Q36200287 | Lack of protein kinase C-α leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension |
Q37510779 | NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity |
Q36940474 | NF-kappaB modulates aquaporin-2 transcription in renal collecting duct principal cells |
Q64891802 | New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus. |
Q44185774 | Osmolality and solute composition are strong regulators of AQP2 expression in renal principal cells |
Q37418657 | P2Y(2) receptors and water transport in the kidney. |
Q33567274 | PKCα regulates vasopressin-induced aquaporin-2 trafficking in mouse kidney collecting duct cells in vitro via altering microtubule assembly |
Q38528569 | Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. |
Q37018451 | Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout mice |
Q57051332 | Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus |
Q37260229 | Proteome-wide measurement of protein half-lives and translation rates in vasopressin-sensitive collecting duct cells |
Q36510644 | Proteomic profiling of nuclear fractions from native renal inner medullary collecting duct cells |
Q33675300 | Proteomic profiling of nuclei from native renal inner medullary collecting duct cells using LC-MS/MS |
Q36382466 | Quantitative phosphoproteomics in nuclei of vasopressin-sensitive renal collecting duct cells |
Q35982335 | Quantitative proteomics identifies vasopressin-responsive nuclear proteins in collecting duct cells. |
Q40622367 | Renal principal cell-specific expression of green fluorescent protein in transgenic mice |
Q90309197 | Soluble (pro)renin receptor as a potential therapy for diabetes insipidus |
Q44185883 | Synergistic effects of nitric oxide and prostaglandins on renal escape from vasopressin-induced antidiuresis |
Q37114912 | Systems-level analysis of cell-specific AQP2 gene expression in renal collecting duct |
Q33831383 | Targeting of membrane transporters in renal epithelia: when cell biology meets physiology |
Q90335855 | Targeting the Trafficking of Kidney Water Channels for Therapeutic Benefit |
Q26768170 | The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases |
Q36512949 | Transcriptional profiling of native inner medullary collecting duct cells from rat kidney |
Q34279269 | Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output |
Q44838094 | Upregulation of collecting duct aquaporin-2 by metabolic acidosis: role of vasopressin |
Q52890485 | Vasopressin V(2)-receptor-dependent regulation of AQP2 expression in Brattleboro rats. |
Q37179035 | Vasopressin and the regulation of aquaporin-2 |
Q38515104 | Vasopressin regulation of sodium transport in the distal nephron and collecting duct |
Q78089622 | [Physiopathology of diabetes insipidus] |
Search more.